Equity Research, Broker Reports, and media content on Renalytix Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Renalytix Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Renalytix Plc

Company Profile

  • Personnel
  • James Renwick McCullough, CEO
  • James Sterling, CFO
  • Sally Bowden, COO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Renalytix Plc. We currently have 167 research reports from 4 professional analysts.

  • Open: 525p
  • Range Today: 500/564p
  • 52 Week: 500/1220p
  • Daily Volume: 95.3k
  • Daily Liquidity: (0.13%)
  • # Shares: 72.3m
  • Market Cap: £401.3m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
11Jan22 13:06 RNS Renalytix PLC - Positive Study Results Published for KidneyIntelX
10Jan22 07:00 RNS Renalytix PLC - Partnership with Singing River for KidneyIntelX
07Jan22 07:00 RNS Renalytix PLC - Appointment of Jean M. Casner as CHRO
05Jan22 07:00 RNS Renalytix PLC - RENX to present at 40th JP Morgan Healthcare Conf.
04Jan22 07:00 RNS Renalytix PLC - Joint program with American Diabetes Association
17Dec21 15:38 RNS Renalytix PLC - Result of AGM
17Dec21 11:26 RNS Renalytix PLC - Director/PDMR Shareholding
  • Frequency of research reports

     

  • Research reports on

    Renalytix Plc

  • Providers covering

    Renalytix Plc